Alkermes Announces Continued Board Refreshment, Including the Appointment of Christopher I. Wright, M.D., Ph.D. to its Board of Directors

– Appoints Nancy J. Wysenski as New Lead Independent Director –

– David W. Anstice AO and Wendy L. Dixon, Ph.D. to Retire From Board –

– Files Preliminary Proxy Statement and Highlights Shareholder Engagement Efforts –

DUBLIN, May 26, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced a series of actions as part of its ongoing commitment to strong corporate governance and regular board refreshment. The company also filed its preliminary proxy statement with the U.S. Securities and Exchange Commission (SEC) in connection with its upcoming Annual General Meeting of Shareholders (the Annual Meeting). The preliminary proxy statement is available on the Investor Relations section of the company's website at

More on Boston Chron
Filed Under: Business

Show All News | Report Violation


Latest on Boston Chron